Adrienne Cox, PhD
Professor of Radiation Oncology and Pharmacology
Director of the Cancer Biology Division
Cancer Biologist
Dr. Cox concentrates on signaling from Ras and Rho family small GTPases in pancreatic and colorectal cancer models.
Our Cancer Biology Division has as its focus the molecular underpinnings of cancer etiology and radiation response, and application of this knowledge to new cancer drug discovery.
The Division consists of four faculty members whose research efforts encompass both mechanistic studies of the basis of cancer development and maintenance and translational research into molecular target validation and new drug and biomarker discovery. Similarly, our research on cellular responses to radiation bridges both types of research. Our internationally recognized investigators use state-of-the-art model systems and animal-, cell- and in vitro–based biological, biochemical, and molecular biology techniques to study oncogenes and tumor suppressor genes.
We are a highly collaborative group and maintain close associations with colleagues within the department, the UNC Lineberger Comprehensive Cancer Center, and with top investigators both nationally and internationally from academia and the pharmaceutical industry.
Professor of Radiation Oncology and Pharmacology
Director of the Cancer Biology Division
Cancer Biologist
Dr. Cox concentrates on signaling from Ras and Rho family small GTPases in pancreatic and colorectal cancer models.
Associate Professor
Radiation Oncology Physician-Scientist
Associate Chair for Research
UNC Radiation Oncology - Chapel Hill
Breast cancer
Adjunct Professor
Radiation Biologist and Educator
Dr. Zeman is a clinically oriented radiation biologist who devotes herself to the biology teaching needs of our radiation oncology residents, medical physics and biomedical engineering graduate students, and radiation therapy and medical dosimetry trainees.